LU82612A1 - Derives de tallysomycine,leur procede de production et medicament les contenant - Google Patents

Derives de tallysomycine,leur procede de production et medicament les contenant Download PDF

Info

Publication number
LU82612A1
LU82612A1 LU82612A LU82612A LU82612A1 LU 82612 A1 LU82612 A1 LU 82612A1 LU 82612 A LU82612 A LU 82612A LU 82612 A LU82612 A LU 82612A LU 82612 A1 LU82612 A1 LU 82612A1
Authority
LU
Luxembourg
Prior art keywords
tallysomycin
derivative
derivatives
strain
tally
Prior art date
Application number
LU82612A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU82612A1 publication Critical patent/LU82612A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU82612A 1979-07-13 1980-07-11 Derives de tallysomycine,leur procede de production et medicament les contenant LU82612A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5752879 1979-07-13
US06/057,528 US4246400A (en) 1979-07-13 1979-07-13 Tallysomycin compounds

Publications (1)

Publication Number Publication Date
LU82612A1 true LU82612A1 (fr) 1981-02-02

Family

ID=22011128

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82612A LU82612A1 (fr) 1979-07-13 1980-07-11 Derives de tallysomycine,leur procede de production et medicament les contenant

Country Status (26)

Country Link
US (1) US4246400A (no)
JP (1) JPS5659793A (no)
AU (1) AU533469B2 (no)
BE (1) BE884291A (no)
CA (1) CA1144494A (no)
CH (1) CH646982A5 (no)
CY (1) CY1317A (no)
DE (1) DE3026425A1 (no)
DK (1) DK151633C (no)
ES (1) ES493350A0 (no)
FI (1) FI67876C (no)
FR (1) FR2460961A1 (no)
GB (1) GB2053221B (no)
GR (1) GR82324B (no)
HK (1) HK8286A (no)
IE (1) IE50020B1 (no)
IL (1) IL60541A (no)
IT (1) IT1174296B (no)
LU (1) LU82612A1 (no)
MY (1) MY8800097A (no)
NL (1) NL8003970A (no)
NO (1) NO155701C (no)
NZ (1) NZ193921A (no)
SE (1) SE449751B (no)
YU (1) YU43218B (no)
ZA (1) ZA804150B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058838A1 (en) * 1981-02-23 1982-09-01 American Cyanamid Company Antibiotic LL BO1208 alpha and LL BO1208 beta
US4650765A (en) * 1981-02-23 1987-03-17 American Cyanamid Company Biologically pure culture of Streptoverticillium stramineum sp. nov.
JPH02267083A (ja) * 1989-04-07 1990-10-31 Nissan Motor Co Ltd 自動車のフロントボデー補強構造
US5420228A (en) * 1991-04-05 1995-05-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Fluorescent-labelled bleomycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038242A (en) * 1963-03-05 1966-08-10 Zaidan Hojin Biseibutsu Bleomycin and processes for preparation thereof
GB1292081A (en) * 1969-02-15 1972-10-11 Zaidan Hojin Biseibutsu Process for producing bleomycin antibiotics
US3846400A (en) * 1969-02-15 1974-11-05 Microbial Chem Res Found Novel process for producing antibiotics bleomycin
US3814796A (en) * 1969-10-09 1974-06-04 Upjohn Co Antibiotics zorbonomycin and zorbonomycin b and process for the preparation thereof
US3922262A (en) * 1971-04-28 1975-11-25 Nippon Kayaku Kk N-Substituted derivatives of bleomycins
JPS5739751B2 (no) * 1972-03-03 1982-08-23
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same
US4195018A (en) * 1977-07-01 1980-03-25 Nippon Kayaku Kabushiki Kaisha 3-[(S)-1'-Phenylethylamino]propylaminobleomycin, non-toxic salt thereof, and method for producing same

Also Published As

Publication number Publication date
NZ193921A (en) 1982-09-14
HK8286A (en) 1986-02-14
YU143580A (en) 1983-04-30
NL8003970A (nl) 1981-01-15
ZA804150B (en) 1981-07-29
CA1144494A (en) 1983-04-12
JPS6328080B2 (no) 1988-06-07
AU533469B2 (en) 1983-11-24
FR2460961A1 (fr) 1981-01-30
ES8106554A1 (es) 1981-07-01
GB2053221A (en) 1981-02-04
DK297980A (da) 1981-01-14
BE884291A (fr) 1981-01-12
AU5919080A (en) 1981-01-15
IT1174296B (it) 1987-07-01
IL60541A (en) 1983-12-30
IE801444L (en) 1981-01-13
FI67876B (fi) 1985-02-28
CY1317A (en) 1986-03-28
CH646982A5 (fr) 1984-12-28
MY8800097A (en) 1988-12-31
NO155701B (no) 1987-02-02
JPS5659793A (en) 1981-05-23
ES493350A0 (es) 1981-07-01
DK151633B (da) 1987-12-21
DK151633C (da) 1988-06-20
NO802048L (no) 1981-01-14
US4246400A (en) 1981-01-20
IT8049183A0 (it) 1980-07-07
DE3026425C2 (no) 1989-11-09
GB2053221B (en) 1983-05-05
FR2460961B1 (no) 1983-11-18
IL60541A0 (en) 1980-09-16
SE449751B (sv) 1987-05-18
SE8005134L (sv) 1981-01-14
GR82324B (no) 1984-12-13
DE3026425A1 (de) 1981-01-29
NO155701C (no) 1987-05-13
IE50020B1 (en) 1986-02-05
FI67876C (fi) 1985-06-10
FI802198A (fi) 1981-01-14
YU43218B (en) 1989-06-30

Similar Documents

Publication Publication Date Title
EP0739344B1 (en) Antiparasitic pyrrolobenzoxazine compounds
EP0366060B1 (de) Glykosidase-Inhibitor Salbostatin, Verfahren zu seiner Herstellung und seine Verwendung
JPH0637508B2 (ja) 抗生物質Ａ４０９２６複合体およびその純粋な因子ＰＡ、ＰＢ、Ａ、ＢおよびＢｏ
CH655127A5 (fr) Antibiotiques peptidiques et leur procede de production.
JP2873340B2 (ja) 抗生物質ｔａｎ―１０５７，その製造法および用途
FR2489819A1 (fr) Antibiotique bmg162-af2 ayant notamment une activite antitumorale et son procede de preparation a partir d'une souche du genre bacillus
JPS6316120B2 (no)
LU82612A1 (fr) Derives de tallysomycine,leur procede de production et medicament les contenant
SU867318A3 (ru) Способ получени баумицина а и в
FR2568892A1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
US5155041A (en) Culture of Bacillus subtilis
JP2863637B2 (ja) 新規なアミノオリゴ糖誘導体およびその製造方法
FR2490223A1 (fr) Nouveau peptide, son procede de preparation et culture du microorganisme utilise dans ce procede
CA2012013C (en) Antitumor antibiotic bmy-41339
DE2638766A1 (de) Antibiotischer glykopeptidkomplex, verfahren zu seiner herstellung und diese enthaltende mittel
US5451581A (en) Antibiotic LL-14E605β and O-methyl-LL-14E605β
JPH0341477B2 (no)
US4314028A (en) Fermentation process for producing tallysomycin compounds
CA2017276C (en) Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof
EP0024206A2 (en) Antitumor substance, composition comprising it and process for preparing said substance
JPH01240196A (ja) 新規グリコペプチド系抗生物質ｐａ−４５０５２
FR2463618A1 (fr) Nouvel antibiotique aminoglycoside et sa production
JPH0733395B2 (ja) 抗生物質ｔａｎ−９２８およびその製造法
JPH0788364B2 (ja) 新規物質アロサミゾリン
JPH0434522B2 (no)